9,9-Bis[4-[N-(1-naphthyl)anilino]phenyl]fluorene>97.0%(HPLC)(N)200mg

4-fluoro-N-(3-morpholin-4-ylpropyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

2-Chloro-6-methylisonicotinonitrile, 95.0%, 25g

7-(4-Chlorophenyl)-5,6-dimethyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine, 97%, 250mg

3-Bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 95.0%, 500mg

Z-DL-aspartic acid b-benzyl ester, 99.0%, 1g

Methyl 2-(4-(4-hydroxyphenyl)cyclohexyl)acetate, 98%, 1g

PSI 7411, 97%, 100mg

4,4,5,5-Tetramethyl-2-phenethyl-1,3,2-dioxaborolane, 95.0%, 1g

Receptor de vacío recto, 14/23, 14/23, 1 pieza

1-Methyl-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 500g

3-Thiomorpholinecarboxylic acid, 97.0%, 1g

3-Benzyl 1-tert-butyl azetidine-1,3-dicarboxylate, 97%, 100mg